Compare GSK & BX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GSK | BX |
|---|---|---|
| Founded | 1715 | 1985 |
| Country | United Kingdom | United States |
| Employees | N/A | 4895 |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.0B | 121.9B |
| IPO Year | N/A | 2007 |
| Metric | GSK | BX |
|---|---|---|
| Price | $50.34 | $156.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 15 |
| Target Price | N/A | ★ $180.13 |
| AVG Volume (30 Days) | 3.4M | ★ 3.6M |
| Earning Date | 02-04-2026 | 01-29-2026 |
| Dividend Yield | ★ 3.33% | 2.51% |
| EPS Growth | ★ 118.57 | 19.48 |
| EPS | 1.79 | ★ 3.48 |
| Revenue | ★ $43,237,357,842.00 | $12,791,218,000.00 |
| Revenue This Year | $6.70 | $3.97 |
| Revenue Next Year | $5.10 | $24.91 |
| P/E Ratio | ★ $28.21 | $45.30 |
| Revenue Growth | 2.73 | ★ 14.84 |
| 52 Week Low | $31.72 | $115.66 |
| 52 Week High | $51.46 | $190.09 |
| Indicator | GSK | BX |
|---|---|---|
| Relative Strength Index (RSI) | 63.33 | 54.29 |
| Support Level | $50.02 | $147.52 |
| Resistance Level | $51.46 | $158.29 |
| Average True Range (ATR) | 0.58 | 3.84 |
| MACD | 0.06 | -0.11 |
| Stochastic Oscillator | 61.99 | 57.24 |
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Blackstone is the world's largest alternative-asset manager with $1.242 trillion in total asset under management, including $906.2 billion in fee-earning assets under management, at the end of September 2025. The company operates with scale in each of its major product lines: private equity (26% of fee-earning AUM and 33% of base management fees), real estate/real assets (31% and 35%), private credit (34% and 25%), and other alternatives (9% and 7%). While the firm primarily serves institutional investors (84% of AUM), it also caters to clients in the high-net-worth channel (16%). Blackstone operates through 25 offices in the Americas (8), Europe and the Middle East (9), and the Asia-Pacific region (8).